Michael Ghadimi

5PUBLICATIONS
74CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples theory of change models for health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 12, 2026
Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

|Aug 13, 2025
Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.

Rainer Fietkau, Michael Ghadimi, Robert Grützmann

|Jul 04, 2025
TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer.

Laura Urbach, Lena Wieland, Frederike Penz

|Feb 21, 2025
Ideal Outcome after Left Pancreatectomy in North America, Germany, the Netherlands, and Sweden.

Tessa E Hendriks, Simone Augustinus, Bodil Andersson

|Jul 15, 2024
Tumor Vessel Normalization via PFKFB3 Inhibition Alleviates Hypoxia and Increases Tumor Necrosis in Rectal Cancer upon Radiotherapy.

Marcus Edelmann, Shuang Fan, Tiago De Oliveira

Pageof 1

Frequent Collaborators

2 joint publications

Christof Lenz

2 joint publications

Lena-Christin Conradi

1 joint publications

Marcus Edelmann

1 joint publications

Shuang Fan